Vertex to acquire Semma Therapeutics

PROVIDENCE – Vertex Pharmaceuticals Inc. has entered into an agreement to acquire Semma Therapeutics for $950 million in cash, the companies announced Tuesday. Both companies are headquartered in the biotech hub Kendall Square neighborhood in Cambridge, Mass. Semma Therapeutics, in 2015, acquired CytoSolv Inc., a Providence-based startup that received early-stage funding from Slater Technology Fund,…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -